Ebola Outbreak in DRC Surpasses 1,000 Cases – Fastest-Growing Epidemic on Record

Ebola Outbreak in DRC Surpasses 1,000 Cases — Fastest-Growing Epidemic on Record

The ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC) has officially surpassed 1,000 confirmed cases, making it not only the second-largest Ebola outbreak ever recorded but also the fastest-growing in history. Global health authorities are racing to contain the spread as the virus extends into neighbouring Uganda and sparks international concern.

Current Situation: Cases and Deaths

As of 22 June 2026, the DRC Ministry of Health reports 1,048 confirmed cases of Ebola disease caused by the Bundibugyo virus, including 267 confirmed deaths. The outbreak is concentrated in the eastern provinces of Ituri, North Kivu, and South Kivu — a region already grappling with armed conflict, population displacement, and limited healthcare infrastructure.

According to the European Centre for Disease Prevention and Control (ECDC), Ituri province accounts for 954 of the confirmed cases across 22 health zones. North Kivu has reported 91 cases from 11 health zones, while South Kivu has three cases from one health zone.

In neighbouring Uganda, 20 confirmed cases have been reported, including two deaths. Of these, 15 cases had travel links to DRC and five resulted from local transmission events. The most recent case in Uganda was reported on 21 June, and health authorities remain on high alert.

Why This Outbreak Is Different

The World Health Organization (WHO) declared the outbreak a Public Health Emergency of International Concern (PHEIC) on 16 May 2026 — just days after it was first identified. Dr Abdirahman Mahamud, WHO Director of Health Emergency Alert and Response Operations, described the speed of transmission as alarming.

“This is the largest number of confirmed cases in the first month of an Ebola disease outbreak in Africa,” Dr Mahamud said. He noted that the current outbreak took only 37 days to reach 250 deaths. In comparison, the devastating 2014–2016 West Africa outbreak took 78 days to reach the same grim milestone, while the 2018–2019 DRC outbreak took 130 days.

This is the 17th Ebola outbreak in the DRC, and the first caused by the Bundibugyo species since 2012. Unlike the Zaire ebolavirus that caused previous large outbreaks, there is currently no approved vaccine for the Bundibugyo virus. Treatment consists primarily of supportive care, including fluid replacement, oxygen therapy, and management of specific symptoms.

What Is Bundibugyo Virus?

Bundibugyo virus is one of four orthoebolaviruses known to cause Ebola disease in humans. First identified during an outbreak in Uganda in 2007, it has historically caused outbreaks with case fatality rates ranging from 32% to 55%. The current outbreak is now the largest ever caused by this particular species.

Symptoms of Bundibugyo virus infection include:

• Sudden onset of fever and severe weakness
• Muscle pain, headache, and sore throat
• Vomiting and diarrhoea
• Abdominal pain and unexplained bleeding or bruising
• Nosebleeds and vomiting blood in severe cases

The incubation period ranges from 2 to 21 days, meaning exposed individuals may not show symptoms for up to three weeks. The virus spreads through direct contact with bodily fluids of infected people or contaminated surfaces.

International Response and Challenges

The global response has been swift but faces significant hurdles. WHO, the International Organization for Migration (IOM), the International Federation of Red Cross and Red Crescent Societies (IFRC), and the U.S. Centers for Disease Control and Prevention (CDC) have all deployed resources to the affected region.

Treatment capacity has expanded from a handful of beds to over 500 beds across 19 health zones. Laboratory testing capacity has increased dramatically — from 30 tests per day in Kinshasa at the outbreak’s start to over 2,000 tests per day through a network of eight decentralised laboratories across the affected provinces.

IOM reports having screened over one million travellers at key points of entry and along major mobility corridors. However, a significant funding gap remains: of the US$55.8 million required to support cross-border coordination across 11 countries over the next six months, some US$35 million is still unfunded.

Security and community trust remain critical challenges. Armed conflict in eastern DRC complicates access for health workers, and violence against humanitarian personnel — including Red Cross volunteers conducting safe and dignified burials — has been reported. Misinformation and rumours about the disease are hampering response efforts in some communities.

Risk to the United States and Other Countries

The CDC has assessed the risk to the U.S. population as low over the next three months. No Ebola cases associated with this outbreak have been reported in the United States. However, out of an abundance of caution, the U.S. government has implemented enhanced travel screening measures.

Air passengers arriving from DRC, Uganda, and South Sudan are now being re-routed to four designated airports: Washington-Dulles International Airport (IAD), Atlanta Hartsfield-Jackson International Airport (ATL), George Bush Intercontinental Airport in Houston (IAH), and John F. Kennedy International Airport in New York (JFK). Enhanced screening and public health monitoring protocols are in place at these entry points.

The travel restrictions have not been without controversy. A U.S. plan to establish a quarantine facility for exposed American personnel at a Kenyan air base sparked violent protests in the town of Nanyuki. A Kenyan court has suspended the plan pending further legal review, and an American surgeon who contracted Ebola while treating patients in Ituri was evacuated to Germany for treatment instead.

What Travellers Need to Know

The CDC has issued Level 3 travel health notices for the DRC, recommending that travellers avoid all non-essential travel to Ituri, North Kivu, and South Kivu provinces. A Level 2 notice is in effect for Uganda, advising enhanced precautions.

Travellers to affected areas should:

• Avoid contact with symptomatic individuals
• Practice rigorous hand hygiene
• Avoid contact with blood and bodily fluids
• Monitor for symptoms for 21 days after leaving affected areas
• Seek immediate medical attention if fever develops

The ECDC considers the risk of infection for people in Europe as “very low,” but continues to monitor the situation closely.

Frequently Asked Questions About the 2026 Ebola Outbreak

How does this outbreak compare to the 2014 West Africa Ebola epidemic?

The 2014–2016 West Africa outbreak was the largest in history, with over 28,000 cases and 11,000 deaths. The current outbreak has surpassed 1,000 cases in its first month — a significantly faster rate of spread. However, it remains geographically contained to eastern DRC and parts of Uganda. Public health experts warn it could become one of the worst ever recorded if the international response is not rapidly scaled up.

Is there a vaccine for this strain of Ebola?

No. Existing Ebola vaccines, including the Ervebo vaccine widely used during the 2018–2019 DRC outbreak, target the Zaire ebolavirus. There is currently no licensed vaccine for the Bundibugyo virus, which is the species responsible for this outbreak. Research is ongoing, but none are yet available for emergency use.

Should I cancel my travel plans?

If your travel does not involve the affected provinces in eastern DRC or high-risk areas in Uganda, the CDC and WHO advise that no change in behaviour is recommended. However, if you are planning travel to Ituri, North Kivu, or South Kivu provinces in DRC, non-essential travel should be avoided. Always consult official travel health notices before departure.

How is Ebola treated?

Treatment for Ebola disease primarily involves supportive care: intravenous fluids, maintaining oxygen levels and blood pressure, and treating secondary infections. Monoclonal antibody treatments that proved effective against Zaire ebolavirus may not be effective against Bundibugyo virus. Early medical intervention significantly improves survival chances.

Could this outbreak become a global pandemic?

Major global health agencies, including WHO and CDC, currently assess the risk of international spread as low to moderate. The outbreaks remain concentrated in specific regions, and containment measures are being scaled up. However, the rapid pace of transmission and high levels of population movement in the affected mining zones mean that the situation requires sustained vigilance and resources.

This article is for informational purposes only and does not constitute medical advice. Stay informed through official sources such as the World Health Organization (who.int) and the U.S. Centers for Disease Control and Prevention (cdc.gov).